These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 29374975)
1. Synthesis and biological evaluation of stilbene derivatives coupled to NO donors as potential antidiabetic agents. Wang B; Liu T; Wu Z; Zhang L; Sun J; Wang X J Enzyme Inhib Med Chem; 2018 Dec; 33(1):416-423. PubMed ID: 29374975 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and molecular modeling of novel non-sulfonylureas as hypoglycemic agents and selective ALR2 inhibitors. Salem MG; Aziz YMA; Elewa M; Elshihawy HA; Said MM Bioorg Med Chem; 2019 Aug; 27(15):3383-3389. PubMed ID: 31221611 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of 3-arylcoumarin derivatives as potential anti-diabetic agents. Hu Y; Wang B; Yang J; Liu T; Sun J; Wang X J Enzyme Inhib Med Chem; 2019 Dec; 34(1):15-30. PubMed ID: 30362362 [TBL] [Abstract][Full Text] [Related]
4. Chemical Constituents of Smilax china L. Stems and Their Inhibitory Activities against Glycation, Aldose Reductase, α-Glucosidase, and Lipase. Lee HE; Kim JA; Whang WK Molecules; 2017 Mar; 22(3):. PubMed ID: 28287485 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of β-Ketoamide Curcumin Analogs for Anti-Diabetic and AGEs Inhibitory Activities. Banuppriya G; Sribalan R; Fathima SAR; Padmini V Chem Biodivers; 2018 Aug; 15(8):e1800105. PubMed ID: 29752771 [TBL] [Abstract][Full Text] [Related]
6. Substituted 2-thioxothiazolidin-4-one derivatives showed protective effects against diabetic cataract via inhibition of aldose reductase. Huang W; Zhang Y; Liang X; Yang L Arch Pharm (Weinheim); 2020 Jun; 353(6):e1900371. PubMed ID: 32237167 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and evaluation of phenylfuroxan nitric oxide-donor phenols as potential anti-diabetic agents. Xie YD; Shao LH; Wang QT; Bai Y; Li N; Yang G; Li YP; Bian XL Bioorg Chem; 2019 Aug; 89():103000. PubMed ID: 31132604 [TBL] [Abstract][Full Text] [Related]
8. Antidiabetic potential: In vitro inhibition effects of bromophenol and diarylmethanones derivatives on metabolic enzymes. Demir Y; Taslimi P; Ozaslan MS; Oztaskin N; Çetinkaya Y; Gulçin İ; Beydemir Ş; Goksu S Arch Pharm (Weinheim); 2018 Dec; 351(12):e1800263. PubMed ID: 30478943 [TBL] [Abstract][Full Text] [Related]
9. Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera. Jung HA; Islam MN; Lee CM; Oh SH; Lee S; Jung JH; Choi JS Chem Biol Interact; 2013 Oct; 206(1):55-62. PubMed ID: 23994501 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of organic nitrates of luteolin as a novel class of potent aldose reductase inhibitors. Wang QQ; Cheng N; Zheng XW; Peng SM; Zou XQ Bioorg Med Chem; 2013 Jul; 21(14):4301-10. PubMed ID: 23683835 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo inhibition of aldose reductase and advanced glycation end products by phloretin, epigallocatechin 3-gallate and [6]-gingerol. Sampath C; Sang S; Ahmedna M Biomed Pharmacother; 2016 Dec; 84():502-513. PubMed ID: 27685794 [TBL] [Abstract][Full Text] [Related]
12. Exploiting oxadiazole-sulfonamide hybrids as new structural leads to combat diabetic complications via aldose reductase inhibition. Javid N; Munir R; Chaudhry F; Imran A; Zaib S; Muzaffar A; Iqbal J Bioorg Chem; 2020 Jun; 99():103852. PubMed ID: 32325339 [TBL] [Abstract][Full Text] [Related]
13. Glucopyranoside flavonoids isolated from leaves of Spinacia oleracea (spinach) inhibit the formation of advanced glycation end products (AGEs) and aldose reductase activity (RLAR). Perez Gutierrez RM; Velazquez EG Biomed Pharmacother; 2020 Aug; 128():110299. PubMed ID: 32521451 [TBL] [Abstract][Full Text] [Related]
14. Development of non-acidic 4-methylbenzenesulfonate-based aldose reductase inhibitors; Design, Synthesis, Biological evaluation and in-silicostudies. Said GE; Metwally HM; Abdel-Latif E; Elnagar MR; Ibrahim HS; Ibrahim MA Bioorg Chem; 2024 Oct; 151():107666. PubMed ID: 39067420 [TBL] [Abstract][Full Text] [Related]
15. Dihydroxanthyletin-type coumarins from Angelica decursiva that inhibits the formation of advanced glycation end products and human recombinant aldose reductase. Ali MY; Jung HA; Jannat S; Choi JS Arch Pharm Res; 2018 Feb; 41(2):196-207. PubMed ID: 29230690 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and investigation of polyhydroxylated pyrrolidine derivatives as novel chemotypes showing dual activity as glucosidase and aldose reductase inhibitors. Guazzelli L; D'Andrea F; Sartini S; Giorgelli F; Confini G; Quattrini L; Piano I; Nencetti S; Orlandini E; Gargini C; La Motta C Bioorg Chem; 2019 Nov; 92():103298. PubMed ID: 31557624 [TBL] [Abstract][Full Text] [Related]
17. Exploring the Dual Inhibitory Activity of Novel Anthranilic Acid Derivatives towards α-Glucosidase and Glycogen Phosphorylase Antidiabetic Targets: Design, In Vitro Enzyme Assay, and Docking Studies. Ihmaid S Molecules; 2018 May; 23(6):. PubMed ID: 29844263 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of resveratrol in diabetic complications: In vitro and in vivo studies. Ciddi V; Dodda D Pharmacol Rep; 2014 Oct; 66(5):799-803. PubMed ID: 25149983 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of some tetrazole acetamide derivatives as novel non-carboxylic PTP1B inhibitors. Maheshwari N; Karthikeyan C; Bhadada SV; Verma AK; Sahi C; Moorthy NSHN; Trivedi P Bioorg Chem; 2019 Nov; 92():103221. PubMed ID: 31499261 [TBL] [Abstract][Full Text] [Related]
20. Aldose reductase inhibitory and antiglycation properties of phytoconstituents of Cichorium intybus: Potential therapeutic role in diabetic retinopathy. Ahmad S; Ahmad MFA; Alouffi S; Khan S; Khan M; Khan MWA; Prakash C; Ahmad N; Ansari IA Int J Biol Macromol; 2024 Oct; 277(Pt 1):133816. PubMed ID: 39002911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]